PRINT FRIENDLY

HBA Los Angeles presents

The Future of Clinical Trials


Date and time
Tuesday, 14 September
05:00PM - 06:00PM PST
Location
Virtual - Zoom

Event Contact
Audrey McConnell
Competencies
3. Exhibits business and industry acumen
Event Sponsor

Leading clinical trials is one of the pharmaceutical industry’s most costly and time-consuming processes. In this session, we will discuss the current clinical trial environment and identify areas where we can drive meaningful change. With the rising availability of new data sources, increased momentum for patient-centricity, and emergence of new technologies, we can reimagine the clinical trial process. 


Registration information
Event is open to: HBA Members and Nonmembers

Featured Speakers

Heather  McIntire
Managing Director
Accenture
Learning Objectives
Learn how advancements in technology can shape the future of clinical development in the next 10 years and improve the trial process and outcomes for patients

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: Regular Registration

 Member$10.00
 Member - Euro€8.00
 Non-Member$20.00
 Non-Member - Euro€17.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.